• WDC Latin America Summit

    Read the full transcript of Day Two of Brain Health and Cognition in Latin America, held in Buenos Aires on 17 September 2026. Following the results of the LatAm-FINGERS trial, researchers, clinicians, policymakers and advocates from across the region discussed what it would take to move brain health from trial sites to health systems. The conversations cover the unfinished science agenda, what persuades decision-makers, and whether brain health will take off in Latin America.

  • Roundtable on access to treatments in Europe

    Read the transcript of the roundtable on access to treatments in Europe, chaired by Hilary Evans-Newton, Chief Executive of Alzheimer's Research UK, on 24 June 2026. Lorène Gilly of France Alzheimer, David Thomas of Alzheimer's Research UK and Professor Linus Jönsson of Karolinska Institutet set out the position in France, the UK and Sweden. The discussion considered why approved treatments are not reaching patients and how advocacy needs to change.

  • Dialogue on biomarker implementation

    Read the transcript of the dialogue on biomarker implementation, chaired by Dr Fiona Carragher, Chief Research and Policy Officer at Alzheimer's Society, on 9 April 2026. Professor Jeff Burns of the University of Kansas, Dr Argonde van Harten of Alzheimer Center Amsterdam, Dr Mark McClellan of Duke University and Dr Vanessa Raymont of the University of Oxford and Dementias Platform UK described experience in the US, the Netherlands and the UK. The discussion examined how health systems move from new biomarkers to routine diagnosis.

  • Dialogue on brain health advocacy

    Read the transcript of a discussion chaired by Robert Egge chief public policy officer of the Alzheimer's Association, with opening contributions from Harris Eyre Executive Director, Global Brain Economy Initiative, Senior Fellow, Rice University and UTMB, Fred Destrebecq Executive Director of the European Brain Council and Giovanni Frisoni director of the Memory Center at Geneva University.

  • Dialogue on biomarker innovation

    Read the discussion on biomarker innovation chaired by Laura Nisenbaum, executive director of drug development ADDF, and Stacie Weninger, Venture Partner with F-Prime. With contributions from Randall Bateman, Charles F. and Joanne Knight Distinguished Professor of Neurology at WashU, Charlotte Teunissen, Professor in Neurochemistry at VUmc, Michael Weiner ,Professor Radiology and Biomedical imaging, Medicine, Psychiatry, Neurology UCSF and Henrik Zetterberg, professor of neurochemistry at the University of Gothenburg.

  • Dialogue on Innovation in Diagnostics and Treatments

    Read the summary and conclusion of the dialogue on diagnostics and treatment in India, together with the transcript of the opening presentations and roundtable discussion. The meeting was chaired by Professor Suvarna Alladi and Dr Heather M. Snyder, with opening contributions from Faheem Arshad, Suzanne Schindler, Manjari Tripathi and Donna Wilcock, exploring advances in diagnosis, treatment pathways and clinical implementation.

  • Dialogue on Innovation in Brain Health in India

    Read the summary and conclusion of the dialogue on innovation in brain health in India, as well as the transcript of the opening presentation and roundtable discussion. The meeting was chaired by Professors Suvarna Alladi and Miia Kivipelto with opening presentations from Matthew Baumgart, Dr Yogeshwar Kalkonde, Professor Pratima Murthy and Professor Jeff Williamson. 

  • Read About the 2025 WDC Summit

    The dementia field must deliver innovations faster. At the same time, health systems, governments, and communities must be better prepared to rapidly adapt and deploy these innovations. The 2025 WDC Summit brought together politicians, policymakers, academics, industry and advocates to share thinking and insight on how we make progress. 

  • Dialogues on Dementia in Latin America

    Read the outcomes of three dialogues held from November 2024 to March 2025 on research and clinical trials, brain health and social determinants of health, and awareness and understanding. The conversations brought together experts and advocates from across the region to ask how progress can be accelerated and translated into practice.

  • Past Publications

    Read past publications from the World Dementia Council.